Nektar Therapeutics (BMV:NKTR)

Mexico · Delayed Price · Currency is MXN

693.50

-336.50 (-32.67%)

At close: Jan 12, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Applying our Expertise to Develop Novel Drug Candidates	98.43M	90.12M	92.06M	101.91M	152.92M
Applying our Expertise to Develop Novel Drug Candidates Growth	9.22%	-2.10%	-9.67%	-33.36%	33.41%
Total	98.43M	90.12M	92.06M	101.91M	152.92M
Total Growth	9.22%	-2.10%	-9.67%	-33.36%	33.41%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	1.38M	11.48M	9.84M	10.11M	-
United States Growth	-88.02%	16.66%	-2.70%	-	-
Rest of World	97.05M	78.64M	82.21M	91.79M	-
Rest of World Growth	23.41%	-4.35%	-10.44%	-	-
Total	98.43M	90.12M	92.06M	101.91M	-
Total Growth	9.22%	-2.10%	-9.67%	-	-

Source: S&P Global Market Intelligence.